Artivion (AORT) Net Income towards Common Stockholders (2010 - 2026)
Artivion posted quarterly Net Income towards Common Stockholders of $1.4 million for Q1 2026, up 380.59% year-on-year from $294843.4 in Q1 2025, and down 41.59% on a QoQ basis from $2.4 million in Q4 2025.
Artivion (AORT) has 17 years of Net Income towards Common Stockholders data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 380.59% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $11.7 million (up 154.63% YoY), and the FY2025 full-year result was $9.8 million, up 173.12% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $1.4 million, down from $2.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $7.5 million in Q1 2024 and bottomed at -$16.5 million in Q4 2024.
- The 5-year median for Net Income towards Common Stockholders is -$2.3 million (2024), against an average of -$3.1 million.
- The widest annual swing landed in 2024, when Net Income towards Common Stockholders sank 314.67%; it then soared 384.18% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $2.2 million in 2022, then tumbled by 283.26% to -$4.0 million in 2023, then tumbled by 314.67% to -$16.5 million in 2024, then soared by 114.72% to $2.4 million in 2025, then tumbled by 41.59% to $1.4 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $1.4 million (Q1 2026), $2.4 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -505,000.00 |
| Dec 31, 2024 | -16.48 Mn |
| Sep 30, 2024 | -2.29 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -9.80 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Mar 31, 2023 | -13.53 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | -13.71 Mn |
| Jun 30, 2022 | -4.26 Mn |
| Mar 31, 2022 | -3.39 Mn |
| Dec 31, 2021 | -20.10 Mn |
| Sep 30, 2021 | 10.58 Mn |
| Jun 30, 2021 | -2.18 Mn |
| Mar 31, 2021 | -3.14 Mn |
| Dec 31, 2020 | -3.46 Mn |
| Sep 30, 2020 | -2.87 Mn |
| Jun 30, 2020 | -3.69 Mn |
| Mar 31, 2020 | -6.67 Mn |
| Dec 31, 2019 | -9.30 Mn |
| Sep 30, 2019 | -134,000.00 |
| Jun 30, 2019 | 2.83 Mn |
| Mar 31, 2019 | -297,000.00 |
| Dec 31, 2018 | -5.34 Mn |
| Sep 30, 2018 | 1.57 Mn |
| Jun 30, 2018 | 226,000.00 |
| Mar 31, 2018 | -3.86 Mn |
| Dec 31, 2017 | -9.33 Mn |
| Sep 30, 2017 | 1.33 Mn |
| Jun 30, 2017 | 3.16 Mn |
| Mar 31, 2017 | 2.22 Mn |
| Dec 31, 2016 | 5.60 Mn |
| Sep 30, 2016 | 2.99 Mn |
| Jun 30, 2016 | 2.35 Mn |
| Mar 31, 2016 | 2.54 Mn |
| Dec 31, 2015 | -3.07 Mn |
| Sep 30, 2015 | 2.15 Mn |
| Jun 30, 2015 | -502,000.00 |
| Mar 31, 2015 | -274,000.00 |
| Dec 31, 2014 | 1.78 Mn |
| Sep 30, 2014 | 2.33 Mn |
| Jun 30, 2014 | 2.16 Mn |
| Mar 31, 2014 | 1.06 Mn |
| Dec 31, 2013 | 9.35 Mn |
| Sep 30, 2013 | 3.17 Mn |
| Jun 30, 2013 | 1.79 Mn |
| Mar 31, 2013 | 2.19 Mn |
| Dec 31, 2012 | -9.60 Mn |
| Sep 30, 2012 | 1.54 Mn |
| Jun 30, 2012 | 3.26 Mn |
| Mar 31, 2012 | 991,000.00 |
| Dec 31, 2011 | 1.87 Mn |
| Sep 30, 2011 | 2.02 Mn |
| Jun 30, 2011 | 1.78 Mn |
| Mar 31, 2011 | 1.67 Mn |
| Dec 31, 2010 | 391,000.00 |
| Sep 30, 2010 | -3.03 Mn |
| Jun 30, 2010 | 2.93 Mn |